Using modified RECIST and alpha-fetoprotein levels to assess treatment benefit in hepatocellular carcinoma

Jean Luc Raoul, Joong Won Park, Yoon Koo Kang, Richard S. Finn, Jun Suk Kim, Winnie Yeo, Blasé N. Polite, Yee Chao, Ian Walters, Christine Baudelet, Riccardo Lencioni

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'Using modified RECIST and alpha-fetoprotein levels to assess treatment benefit in hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences